Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network

Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences

PDF

School of Medicine Publications and Presentations

Series

2020

Pancreatic cancer

Articles 1 - 3 of 3

Full-Text Articles in Entire DC Network

Ape1 Promotes Pancreatic Cancer Proliferation Through Gfrα1/Src/Erk Axis-Cascade Signaling In Response To Gdnf, Yoo-Duk Choi, Ji-Yeon Jung, Minwoo Baek, Sheema Khan, Peter I. Song, Sunhyo Ryu, Joo-Yeon Koo, Subhash C. Chauhan, Andrew Tsin, Chan Choi, Won Jae Kim, Mihwa Kim May 2020

Ape1 Promotes Pancreatic Cancer Proliferation Through Gfrα1/Src/Erk Axis-Cascade Signaling In Response To Gdnf, Yoo-Duk Choi, Ji-Yeon Jung, Minwoo Baek, Sheema Khan, Peter I. Song, Sunhyo Ryu, Joo-Yeon Koo, Subhash C. Chauhan, Andrew Tsin, Chan Choi, Won Jae Kim, Mihwa Kim

School of Medicine Publications and Presentations

Pancreatic cancer is the worst exocrine gastrointestinal cancer leading to the highest mortality. Recent studies reported that aberrant expression of apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) is involved in uncontrolled cell growth. However, the molecular mechanism of APE1 biological role remains unrevealed in pancreatic cancer progression. Here, we demonstrate that APE1 accelerates pancreatic cancer cell proliferation through glial cell line-derived neurotrophic factor (GDNF)/glial factor receptor α1 (GFRα1)/Src/ERK axis-cascade signaling. The proliferation of endogenous APE1 expressed-MIA PaCa-2, a human pancreatic carcinoma cell line, was increased by treatment with GDNF, a ligand of GFRα1. Either of downregulated APE1 or GFRα1 expression using small interference …


Pectin-Tannic Acid Nano-Complexes Promote The Delivery And Bioactivity Of Drugs In Pancreatic Cancer Cells, Sumeet S. Chauhan, Advait B. Shetty, Elham Hatami, Pallabita Chowdhury, Murali M. Yallapu Mar 2020

Pectin-Tannic Acid Nano-Complexes Promote The Delivery And Bioactivity Of Drugs In Pancreatic Cancer Cells, Sumeet S. Chauhan, Advait B. Shetty, Elham Hatami, Pallabita Chowdhury, Murali M. Yallapu

School of Medicine Publications and Presentations

Pancreatic cancer (PanCa) is a lethal disease. Conventional chemotherapies for PanCa offer severe systemic toxicities. Thus, the development of a successful nanomedicine-based therapeutic regimen with augmented therapeutic efficacy is highly sought. Naturally occurring pectin and modified pectin-based drug delivery systems exhibit remarkable self-targeting ability via galactose residues to various cancer cells. Herein, we developed and used an innovative approach of highly stable nanocomplexes based on modified pectin and tannic acid (MPT-NCs). The nanocomplex formation was enabled by strong intermolecular interactions between pectin and tannic acid under very mild conditions. These nanocomplexes were characterized by particle size and morphology (DLS, TEM, …


Biophysical Changes Caused By Altered Muc13 Expression In Pancreatic Cancer Cells, Andrew E. Massey, Kyle Doxtater, Murali M. Yallapu, Subhash C. Chauhan Jan 2020

Biophysical Changes Caused By Altered Muc13 Expression In Pancreatic Cancer Cells, Andrew E. Massey, Kyle Doxtater, Murali M. Yallapu, Subhash C. Chauhan

School of Medicine Publications and Presentations

Background

Pancreatic cancer is one of the most lethal cancers in the United States. This is partly due to the difficulty in early detection of this disease as well as poor therapeutic responses to currently available regimens. Our previous reports suggest that mucin 13 (MUC13, a transmembrane mucin common to gastrointestinal cells) is aberrantly expressed in this disease state, and has been implicated with a worsened prognosis and an enhanced metastatic potential in PanCa. However, there is virtually no information currently to describe the biophysical ramifications of this protein.

Methods

To demonstrate the biophysical effect of MUC13 in PanCa, we …